RS

Rajesh Sundarrajan

Active Director Director DIN 08093860
DIN 08093860 First appointment Mar 2015 Primary industry Information Technology
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Past companies 6 historical roles
Total affiliations 8 Since Mar 2015
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajesh Sundarrajan

Data last updated:

Rajesh Sundarrajan is a Director at Smart Iops (India) Research Center Private Limited (since 2025) and Director at Aerolyz Biosecure Private Limited (since 2022). The companies operate in Information Technology, Electrnoics and Life Sciences. The largest current company by reported revenue is Smart Iops (India) Research Center Private Limited at ₹5.07 Cr (FY 2024). Earlier, Rajesh Sundarrajan was a Managing Director at Sagenome Private Limited (2024) and Ceo(Kmp) at Eastern Treads Limited (2015–2018) and 4 more.

DIN 08093860
Primary Designation Director
Industry Information Technology
First Appointment 31 Mar 2015
Oldest Company Age 11 yrs
Largest company Smart Iops (India) Research Center Private Limited Β· ₹5.07 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 May 20252014₹5.07 Cr (FY 2024)Active
Aerolyz Biosecure Private Limited U29309KL2022PTC079306
Director12 Dec 20222022Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sagenome Private Limited U33309KL2020PTC062848
Managing Director08 Feb 20242020₹44.6 Lakh (FY 2024)Active
Eastern Treads Limited L25119KL1993PLC007213
Ceo(Kmp)31 Mar 20151993₹60.63 Cr (FY 2025)Active
Aspinwall And Company Limited L74999KL1920PLC001389
Ceo(Kmp)12 Nov 20181920₹342 Cr (FY 2025)Active
Aspinwall Healthcare Private Limited U33100KL2020PTC061704
Director24 Feb 20202020₹65.4 Lakh (FY 2025)Active
Sfs Pharma Logistics Private Limited U63090KL2011PTC029554
Director05 Feb 20192011₹4.97 Cr (FY 2025)Active
Director13 Apr 20182017₹1.9 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Aerolyz Biosecure Private Limited
Smart Iops (India) Research Center Private Limited
Sagenome Private Limited
Eastern Treads Limited
Premium access

Shareholding and investment profile for Rajesh Sundarrajan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Sundarrajan

Rajesh Sundarrajan currently holds 2 directorships: Smart Iops (India) Research Center Private Limited (Director, since 30 May 2025, revenue β‚Ή5.07 Cr (FY 2024)); Aerolyz Biosecure Private Limited (Director, since 12 Dec 2022).

Rajesh Sundarrajan was first appointed on 31 Mar 2015 as Ceo(Kmp) at Eastern Treads Limited. The most recent appointment on record is 30 May 2025 at Smart Iops (India) Research Center Private Limited.

Rajesh Sundarrajan held 6 earlier board appointments: Sagenome Private Limited (Managing Director, 08 Feb 2024 to 07 Oct 2024); Eastern Treads Limited (Ceo(Kmp), 31 Mar 2015 to 10 Nov 2018); Aspinwall And Company Limited (Ceo(Kmp), 12 Nov 2018 to 31 Aug 2022); Aspinwall Healthcare Private Limited (Director, 24 Feb 2020 to 03 Jun 2022); Sfs Pharma Logistics Private Limited (Director, 05 Feb 2019 to 03 Jun 2022); and 1 more.

The current boards of Rajesh Sundarrajan's companies include Chandresh Patel (Smart Iops (India) Research Center Private Limited), Santhakumari Amma Damodaran Nair Radhakrishnan (Smart Iops (India) Research Center Private Limited), Syriac Joseph Palackal (Aerolyz Biosecure Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available